
Most of the survival time accrued with RP1 plus nivolumab in the IGNYTE trial was spent in good health among patients with advanced melanoma after anti–PD-1 therapy.
Stacy Tessler Lindau, MD, MA, discusses potential next steps for the Bionic Breast project.
Stacy Tessler Lindau, MD, MA, discusses future research directions for the Bionic Breast Project. She underscores that the primary objective is to confirm that implanting a neuroprosthetic device on the intercostal nerves that would ordinarily supply the breast with sensation can restore sensation and mitigate pain. If this proof-of-concept is successful, the approach can be further optimized to avoid unnecessary procedures and improve the device.






